High-resolution epidemic simulation using within-host infection and contact data

BMC Public Health

Volumn 18, Issue 1, 2018, Pages

  Nguyen, Van Kinh ^a,b   Mikolajczyk, Rafael ^c,d,e   Hernandez Vargas, Esteban Abelardo ^a,b  

^a FRANKFURT INSTITUTE FOR ADVANCED STUDIES   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c Center for Experimental and Clinical Infection Research   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Age structure; Contact network; Ebola virus; Epidemic; High resolution; Simulation; Within host infection

Indexed keywords

ALGORITHM; ANIMAL; COMPUTER SIMULATION; CONTACT EXAMINATION; EPIDEMIC; HUMAN; INFECTIOUS DISEASE MEDICINE; PROCEDURES; THEORETICAL MODEL; TIME FACTOR; VACCINATION;

ALGORITHMS; ANIMALS; COMPUTER SIMULATION; CONTACT TRACING; EPIDEMICS; HUMANS; INFECTIOUS DISEASE MEDICINE; MODELS, THEORETICAL; TIME FACTORS; VACCINATION;

EID: 85049991075     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-018-5709-x     Document Type: Article

References (79)

1. Gates B. The next epidemic-lessons from Ebola. N Engl J Med. 2015; 372(15):1381-4.
2. Piot P. Public health: Beating Ebola. Nature. 2016; 537(7621):484-5.
3. Lofgren ET, Halloran ME, Rivers CM, Drake JM, Porco TC, Lewis B, Yang W, Vespignani A, Shaman J, Eisenberg JN, Eisenberg MC, Marathe M, Scarpino SV, Alexander KA, Meza R, Ferrari MJ, Hyman JM, Meyers LA, Eubank S. Opinion: Mathematical models: a key tool for outbreak response. Proc Natl Acad Sci USA. 2014; 111(51):18095-6.
4. Willem L, Verelst F, Bilcke J, Hens N, Beutels P. Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015). BMC Infect Dis. 2017; 17(1):612. https://doi.org/10.1186/s12879-017-2699-8.
5. Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. Oxford: OUP Oxford; 1992.
6. Heesterbeek H, Anderson RM, Andreasen V, Bansal S, De Angelis D, Dye C, Eames KTD, Edmunds WJ, Frost SDW, Funk S, Hollingsworth TD, House T, Isham V, Klepac P, Lessler J, Lloyd-Smith JO, Metcalf CJE, Mollison D, Pellis L, Pulliam JRC, Roberts MG, Viboud C. Modeling infectious disease dynamics in the complex landscape of global health. Science. 2015; 347(6227):4339-9. https://doi.org/10.1126/science.aaa4339.
7. Britton T. Stochastic epidemic models: A survey. Math Biosci. 2010; 225(1):24-35. 0910.4443.
8. Hens N, Shkedy Z, Aerts M, Faes C, Van Damme P, Beutels P. Modeling Infectious Disease Parameters Based on Serological and Social Contact Data: A Modern Statistical Perspective. Statistics for Biology and Health. New York: Springer; 2012. https://books.google.de/books?id=IH08pTAoe6QC.
9. Pomeroy LW, Bansal S, Tildesley M, Torres KIM, Moritz M, Xiao N, Carpenter TE, Garabed RB. Data-Driven Models of Foot-and-Mouth Disease Dynamics: A Review. Transboundary Emerg Dis. 2017; 64(3):716-28. https://doi.org/10.1111/tbed.12437.
10. Merler S, Ajelli M, Fumanelli L, Parlamento S, Pastore Y Piontti A, Dean NE, Putoto G, Carraro D, Longini IM, Halloran ME, Vespignani A. Containing Ebola at the Source with Ring Vaccination. PLoS Negl Trop Dis. 2016; 10(11):0005093.
11. Lukens S, DePasse J, Rosenfeld R, Ghedin E, Mochan E, Brown ST, Grefenstette J, Burke DS, Swigon D, Clermont G. A large-scale immuno-epidemiological simulation of influenza A epidemics. BMC Public Health. 2014; 14:1019.
12. World Health Organization. Outbreak communication: Best practices for communicating with the public during an outbreak. Technical report.
13. Nguyen VK, Parra-Rojas C, Hernandez-Vargas EA. The 2017 plague outbreak in Madagascar: data descriptions and epidemic modelling. Epidemics. 2018. pii: S1755-4365(18)30007-0. https://doi.org/10.1016/j.epidem.2018.05.001.
14. World Health Organization. Ebola Situation Report - 7 January 2015 | Ebola. Technical report. http://apps.who.int/ebola/en/status-outbreak/situation-reports/ebola-situation-report-7-january-2015.
15. Lloyd-Smith JO, Funk S, McLean AR, Riley S, Wood JLN. Nine challenges in modelling the emergence of novel pathogens. Epidemics. 2014:1-5. https://doi.org/10.1016/j.epidem.2014.09.002.
16. Handel A, Rohani P. Crossing the scale from within-host infection dynamics to between-host transmission fitness: a discussion of current assumptions and knowledge. Philos Trans R Soc Lond B Biol Sci. 2015;370(1675).
17. Alizon S, Luciani F, Regoes RR. Epidemiological and clinical consequences of within-host evolution. Trends Microbiol. 2011; 19(1):24-32.
18. Chen SC, Chio CP, Jou LJ, Liao CM. Viral kinetics and exhaled droplet size affect indoor transmission dynamics of influenza infection. Indoor Air. 2009; 19(5):401-13.
19. Farber DL, Yudanin NA, Restifo NP. Human memory T cells: generation, compartmentalization and homeostasis. Nat Rev Immunol. 2014; 14(1):24-35.
20. Hernandez-Vargas EA, Wilk E, Canini L, Toapanta FR, Binder SC, Uvarovskii A, Ross TM, Guzman CA, Perelson AS, Meyer-Hermann M. Effects of aging on influenza virus infection dynamics. J. Virol. 2014; 88(8):4123-31.
21. Rozhnova G, Metcalf CJE, Grenfell BT. Characterizing the dynamics of rubella relative to measles: the role of stochasticity. J R Soc Interface. 2013; 10(88):20130643-20130643. https://doi.org/10.1098/rsif.2013.0643.
22. Caudron Q, Mahmud AS, Metcalf CJE, Gottfrethsson M, Viboud C, Cliff AD, Grenfell BT. Predictability in a highly stochastic system: final size of measles epidemics in small populations. J R Soc Interface. 2014; 12(102):20141125. https://doi.org/10.1098/rsif.2014.1125.
23. Finkenstadt BF. A stochastic model for extinction and recurrence of epidemics: estimation and inference for measles outbreaks. Biostatistics. 2002; 3(4):493-510. https://doi.org/10.1093/biostatistics/3.4.493.
24. Murillo LN, Murillo MS, Perelson AS. Towards multiscale modeling of influenza infection. J Theor Biol. 2013; 332:267-90.
25. Day T, Alizon S, Mideo N. Bridging scales in the evolution of infectious disease life histories: theory. Evolution. 2011; 65(12):3448-61.
26. Longini IM, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DA, Halloran ME. Containing pandemic influenza at the source. Science. 2005; 309(5737):1083-7.
27. Cen X, Feng Z, Zhao Y. Emerging disease dynamics in a model coupling within-host and between-host systems. J Theor Biol. 2014; 361:141-51.
28. Almocera AES, Nguyen VK, Hernandez-Vargas EA. Multiscale model within-host and between-host for viral infectious diseases. J Math Biol. 2018; 19(1):1-23. https://doi.org/10.1007/s00285-018-1241-y.
29. Lee BY, Brown ST, Korch G, Cooley PC, Zimmerman RK, Wheaton WD, Zimmer SM, Grefenstette JJ, Bailey RR, Assi T-M, Burke DS. A Computer Simulation of Vaccine Prioritization, Allocation, and Rationing During the 2009 H1N1 Influenza Pandemic. Vaccine. 2010; 28(31):4875-9. https://doi.org/10.1016/j.vaccine.2010.05.002.
30. Rahmandad H, Hu K, Tebbens RJD, Thompson KM. Development of an individual-based model for polioviruses: implications of the selection of network type and outcome metrics. Epidemiol Infect. 2011; 139(6):836-848. https://doi.org/10.2307/27975665.
31. Pastor-Satorras R, Vespignani A. Epidemic spreading in scale-free networks. Phys Rev Let. 2001; 86:3200-3. 0010317.
32. Brown ST, Tai JH, Bailey RR, Cooley PC, Wheaton WD, Potter MA, Voorhees RE, LeJeune M, Grefenstette JJ, Burke DS, McGlone SM, Lee BY. Would school closure for the 2009 H1N1 influenza epidemic have been worth the cost?: a computational simulation of Pennsylvania. BMC Public Health. 2011; 11(1):353. https://doi.org/10.1186/1471-2458-11-353.
33. Eames KTD, Read JM, Edmunds WJ. Epidemic prediction and control in weighted networks. Epidemics. 2009; 1(1):70-76. https://doi.org/10.1016/j.epidem.2008.12.001.
34. Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, Heijne J, Sadkowska-Todys M, Rosinska M, Edmunds WJ. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008; 5(3):74.
35. Horby P, Pham QT, Hens N, Nguyen TT, Le QM, Dang DT, Nguyen ML, Nguyen TH, Alexander N, Edmunds WJ, Tran ND, Fox A, Nguyen TH. Social contact patterns in Vietnam and implications for the control of infectious diseases. PLoS ONE. 2011; 6(2):16965.
36. Pastor-satorras R, Castellano C, Mieghem PV, Vespignani A. Epidemic processes in complex networks. 2015:1-62. arXiv:1408.2701v2.
37. Pellis L, Ball F, Bansal S, Eames K, House T, Isham V, Trapman P. Eight challenges for network epidemic models. Epidemics. 2015; 10:58-62.
38. World Health Organization. Ebola Virus Disease - Democratic Republic of the Congo. http://www.who.int/csr/don/10-may-2018-ebola-drc/en/.
39. Nguyen VK, Binder SC, Boianelli A, Meyer-Hermann M, Hernandez-Vargas EA. Ebola virus infection modeling and identifiability problems. Front Microbiol. 2015; 6:7590. https://doi.org/10.3389/fmicb.2015.00257.
40. Nguyen VK, Klawonn F, Mikolajczyk R, Hernandez-Vargas EA. Analysis of Practical Identifiability of a Viral Infection Model. PLoS ONE. 2016; 11(12):0167568. https://doi.org/10.1371/journal.pone.0167568.
41. Nguyen VK, Hernandez-Vargas EA. Windows of opportunity for Ebola virus infection treatment and vaccination. Sci Rep. 2017; 7(1):8975. https://doi.org/10.1038/s41598-017-08884-0.
42. Prescott JB, Marzi A, Safronetz D, Robertson SJ, Feldmann H, Best SM. Immunobiology of Ebola and Lassa virus infections. Nat Rev Immunol. 2017; 17(3):195-207.
43. Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, Fausther-Bovendo H, Wei H, Aviles J, Hiatt E, Johnson A, Morton J, Swope K, Bohorov O, Bohorova N, Goodman C, Kim D, Pauly MH, Velasco J, Pettitt J, Olinger GG, Whaley K, Xu B, Strong JE, Zeitlin L, Kobinger GP. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature. 2014; 514(7520):47-53.
44. Marzi A, Robertson SJ, Haddock E, Feldmann F, Hanley PW, Scott DP, Strong JE, Kobinger G, Best SM, Feldmann H. EBOLA VACCINE, VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain. Science. 2015; 349(6249):739-42.
45. Nowak M, May RM. Virus Dynamics : Mathematical Principles of Immunology and Virology: Mathematical Principles of Immunology and Virology. Oxford: Oxford University Press; 2000.
46. Sullivan N, Yang Z, Nabel GJ. Ebola virus pathogenesis: implications for vaccines and therapies,. J Virol. 2003; 77(18):9733-7.
47. Madelain V, Nguyen TH, Olivo A, de Lamballerie X, Guedj J, Taburet AM, Mentre F. Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials. Clin Pharmacokinet. 2016; 55(8):907-23.
48. Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Gsell PS, Hossmann S, Watle SV, Konde MK, Keita S, Kone S, Kuisma E, Levine MM, Mandal S, Mauget T, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Rottingen JA, Kieny MP. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet. 2017; 389(10068):505-18.
49. Li J, Duan HJ, Chen HY, Ji YJ, Zhang X, Rong YH, Xu Z, Sun LJ, Zhang JY, Liu LM, Jin B, Zhang J, Du N, Su HB, Teng GJ, Yuan Y, Qin EQ, Jia HJ, Wang S, Guo TS, Wang Y, Mu JS, Yan T, Li ZW, Dong Z, Nie WM, Jiang TJ, Li C, Gao XD, Ji D, Zhuang YJ, Li L, Wang LF, Li WG, Duan XZ, Lu YY, Sun ZQ, Kanu AB, Koroma SM, Zhao M, Ji JS, Wang FS. Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients. Int J Infect Dis. 2016; 42:34-9.
50. Agarwal S, Cunningham-Rundles C. Assessment and clinical interpretation of reduced IgG values. Ann Allergy Asthma Immunol. 2007; 99(3):281-3.
51. Feldmann H, Geisbert TW. Ebola haemorrhagic fever,. Lancet (London, England). 2011; 377(9768):849-62.
52. Akerlund E, Prescott J, Tampellini L. Shedding of Ebola virus in an asymptomatic pregnant woman,. N Engl J Med. 2015; 372(25):2467-9.
53. Statistics Sierra Leone (SSL) and ICF International. Sierra Leone Demographic and Health Survey 2013: Freetown, Sierra Leone and Rockville, Maryland, USA: SSL and ICF International; 2014.
54. World Health Organization. What We Know About Transmission of the Ebola Virus Among Humans: Ebola situation assessment; 2014. http://www.who.int/mediacentre/news/ebola/06-october-2014/en/.
55. Lipton J. Care and burial practices in urban Sierra Leone. 2014. http://www.ebola-anthropology.net/wp-content/uploads/2014/11/care-and-burial-practice.pdf.
56. Funk S, Bansal S, Bauch CT, Eames KT, Edmunds WJ, Galvani AP, Klepac P. Nine challenges in incorporating the dynamics of behaviour in infectious diseases models. Epidemics. 2015; 10:21-25.
57. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2015. https://www.R-project.org/.
58. Soetaert K, Cash J, Mazzia F. Solving Differential Equations in R. Berlin, Heidelberg: Springer; 2012. https://doi.org/10.1007/978-3-642-28070-2. http://link.springer.com/10.1007/978-3-642-28070-2.
59. Csardi G, Nepusz T. The igraph software package for complex network research. InterJournal. 2006; Complex Systems:1695.
60. World Health Organization. List of Blueprint priority diseases. Cambridge: WHO; 2018.
61. Csardi G, Nepusz T. The igraph software package for complex network research. InterJournal. 2006; Complex Systems:1695.
62. Peixoto TP. The graph-tool python library. figshare. 2014. https://doi.org/10.6084/m9.figshare.1164194. Accessed 10 Sep 2014.
63. World Health Organization. Immunization Coverage: Geneva: World Health Organization; 2010.
64. Keeling MJ, Rohani P. Modeling Infectious Diseases in Humans and Animals. Princeton: Princeton University Press; 2011.
65. Metcalf CJE, Andreasen V, Bjørnstad ON, Eames K, Edmunds WJ, Funk S, Hollingsworth TD, Lessler J, Viboud C, Grenfell BT. Seven challenges in modeling vaccine preventable diseases. Epidemics. 2015; 10:11-15. https://doi.org/10.1016/j.epidem.2014.08.004.
66. Centers for Disease Control and Prevention and World Health Organization. Implementation and Management of Contact Tracing for Ebola Virus Disease: Emergency Guideline. 2015.
67. Nishiura H. Early efforts in modeling the incubation period of infectious diseases with an acute course of illness. Emerg Themes Epidemiol. 2007; 4(1):2. https://doi.org/10.1186/17622-4-2.
68. Obadia T, Haneef R, Boelle PY. The R0 package: a toolbox to estimate reproduction numbers for epidemic outbreaks. BMC Med Inform Decis Mak. 2012; 12:147. https://doi.org/10.1186/1472-6947-12-147.
69. Virlogeux V, Fang VJ, Park M, Wu JT, Cowling BJ. Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia. Sci Rep. 2016; 6:35839.
70. Martínez MJ, Salim AM, Hurtado JC, Kilgore PE. Ebola Virus Infection: Overview and Update on Prevention and Treatment. Infect Dis Ther. 2015; 4(4):365-30. https://doi.org/10.1007/s40121-015-0079-5.
71. Pastor-Satorras R, Castellano C, Van Mieghem P, Vespignani A. Epidemic processes in complex networks. Rev Mod Phys. 2015; 87(3):925.
72. Bisset KR, Chen J, Feng X, Kumar VSA, Marathe MV. EpiFast: a Fast Algorithm for Large Scale Realistic Epidemic Simulations on Distributed Memory Systems. a fast algorithm for large scale realistic epidemic simulations on distributed memory systems. New York, New York, USA: ACM; 2009. https://doi.org/10.1145/1542275.1542336.
73. Heffernan JM, Smith RJ, Wahl LM. Perspectives on the basic reproductive ratio. Journal of The Royal Society Interface. 2005; 2(4):281-293.
74. Camacho A, Kucharski AJ, Funk S, Breman J, Piot P, Edmunds WJ. Potential for large outbreaks of Ebola virus disease. Epidemics. 2014; 9:70-78. https://doi.org/10.1016/j.epidem.2014.09.003.
75. Bansal S, Grenfell BT, Meyers LA. When individual behaviour matters: homogeneous and network models in epidemiology. J R Soc Interface. 2007; 4(16):879-91. https://doi.org/10.1098/rsif.2007.1100.
76. Abbas AK. B Cell Activation and Antibody Production. In: Cellular and Molecular Immunology. Elsevier Health Sciences: 2011. p. 1-26.
77. Vegvari C, Hadjichrysanthou C, Cauët E, Lawrence E, Cori A, de Wolf F, Anderson RM. How Can Viral Dynamics Models Inform Endpoint Measures in Clinical Trials of Therapies for Acute Viral Infections?PLoS ONE. 2016; 11(7):0158237-13. https://doi.org/10.1371/journal.pone.0158237.
78. Bowman A, Azzalini A. R Package sm: Nonparametric Smoothing Methods (version 2.2-5.4). 2014.
79. Van Kerkhove MD, Bento AI, Mills HL, Ferguson NM, Donnelly CA. A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making. Sci Data. 2015; 2:150019.